Sapir Alex 4
4 · Dova Pharmaceuticals, Inc. · Filed Dec 27, 2017
Insider Transaction Report
Form 4
Sapir Alex
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-12-22−26,809→ 887,291 totalExercise: $3.73Exp: 2027-03-27→ Common Stock (26,809 underlying) - Exercise/Conversion
Common Stock
2017-12-22$3.73/sh+26,809$99,998→ 46,909 total
Footnotes (1)
- [F1]The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of Common Stock and shall vest over a period of four years as follows: (i) 25% of the total shares subject to the option shall vest on January 3, 2018, and (ii) 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service with the Issuer as of each such date.